127 related articles for article (PubMed ID: 15993364)
1. Lipopolysaccharide binding protein-deficient mice have a normal defense against pulmonary mycobacterial infection.
Branger J; Leemans JC; Florquin S; Speelman P; Golenbock DT; van der Poll T
Clin Immunol; 2005 Aug; 116(2):174-81. PubMed ID: 15993364
[TBL] [Abstract][Full Text] [Related]
2. LPS-binding protein-deficient mice have an impaired defense against Gram-negative but not Gram-positive pneumonia.
Branger J; Florquin S; Knapp S; Leemans JC; Pater JM; Speelman P; Golenbock DT; van der Poll T
Int Immunol; 2004 Nov; 16(11):1605-11. PubMed ID: 15452020
[TBL] [Abstract][Full Text] [Related]
3. Gene therapy with lipopolysaccharide binding protein for gram-negative pneumonia: respiratory physiology.
Hemmila MR; Kim J; Sun JM; Cannon J; Arbabi S; Minter RM; Su GL; Remick DG; Wang SC
J Trauma; 2006 Sep; 61(3):598-605; discussion 605-6. PubMed ID: 16966994
[TBL] [Abstract][Full Text] [Related]
4. Lipopolysaccharide-binding protein modulates hepatic damage and the inflammatory response after hemorrhagic shock and resuscitation.
Lehnert M; Uehara T; Bradford BU; Lind H; Zhong Z; Brenner DA; Marzi I; Lemasters JJ
Am J Physiol Gastrointest Liver Physiol; 2006 Sep; 291(3):G456-63. PubMed ID: 16614372
[TBL] [Abstract][Full Text] [Related]
5. Toll-like receptor 2-deficient mice succumb to Mycobacterium tuberculosis infection.
Drennan MB; Nicolle D; Quesniaux VJ; Jacobs M; Allie N; Mpagi J; Frémond C; Wagner H; Kirschning C; Ryffel B
Am J Pathol; 2004 Jan; 164(1):49-57. PubMed ID: 14695318
[TBL] [Abstract][Full Text] [Related]
6. CD27 contributes to the early systemic immune response to Mycobacterium tuberculosis infection but does not affect outcome.
Wieland CW; Kerver ME; Florquin S; Nolte MA; Borst J; van Lier R; van Oers MH; van der Poll T
Int Immunol; 2006 Nov; 18(11):1531-9. PubMed ID: 16966496
[TBL] [Abstract][Full Text] [Related]
7. Delayed recruitment of lymphocytes into the lungs of CD30-deficient mice during aerogenic Mycobacterium avium infections.
Flórido M; McColl SR; Appelberg R
Immunobiology; 2009; 214(8):643-52. PubMed ID: 19250702
[TBL] [Abstract][Full Text] [Related]
8. Lipopolysaccharide-binding protein is required to combat a murine gram-negative bacterial infection.
Jack RS; Fan X; Bernheiden M; Rune G; Ehlers M; Weber A; Kirsch G; Mentel R; Fürll B; Freudenberg M; Schmitz G; Stelter F; Schütt C
Nature; 1997 Oct; 389(6652):742-5. PubMed ID: 9338787
[TBL] [Abstract][Full Text] [Related]
9. Retinoic acid amplifies the host immune response to LPS through increased T lymphocytes number and LPS binding protein expression.
Seguin-Devaux C; Hanriot D; Dailloux M; Latger-Cannard V; Zannad F; Mertes PM; Longrois D; Devaux Y
Mol Cell Endocrinol; 2005 Dec; 245(1-2):67-76. PubMed ID: 16309824
[TBL] [Abstract][Full Text] [Related]
10. Mice overexpressing p40 in lungs have reduced leucocyte influx and slightly impaired resistance during tuberculosis.
Leemans JC; Wieland CW; Florquin S; van der Poll T; Vervoordeldonk MJ
Immunology; 2006 Mar; 117(3):409-18. PubMed ID: 16476061
[TBL] [Abstract][Full Text] [Related]
11. LPS-binding protein protects mice from septic shock caused by LPS or gram-negative bacteria.
Lamping N; Dettmer R; Schröder NW; Pfeil D; Hallatschek W; Burger R; Schumann RR
J Clin Invest; 1998 May; 101(10):2065-71. PubMed ID: 9593762
[TBL] [Abstract][Full Text] [Related]
12. [Frontier of mycobacterium research--host vs. mycobacterium].
Okada M; Shirakawa T
Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
[TBL] [Abstract][Full Text] [Related]
13. Non-LPS targets and actions of LPS binding protein (LBP).
Schröder NW; Schumann RR
J Endotoxin Res; 2005; 11(4):237-42. PubMed ID: 16176661
[TBL] [Abstract][Full Text] [Related]
14. LBP and CD14 secreted in tears by the lacrimal glands modulate the LPS response of corneal epithelial cells.
Blais DR; Vascotto SG; Griffith M; Altosaar I
Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4235-44. PubMed ID: 16249503
[TBL] [Abstract][Full Text] [Related]
15. Activation of tumor-associated macrophages by the vascular disrupting agent 5,6-dimethylxanthenone-4-acetic acid induces an effective CD8+ T-cell-mediated antitumor immune response in murine models of lung cancer and mesothelioma.
Jassar AS; Suzuki E; Kapoor V; Sun J; Silverberg MB; Cheung L; Burdick MD; Strieter RM; Ching LM; Kaiser LR; Albelda SM
Cancer Res; 2005 Dec; 65(24):11752-61. PubMed ID: 16357188
[TBL] [Abstract][Full Text] [Related]
16. Infection of mice with Mycobacterium avium primes CD8+ lymphocytes for apoptosis upon exposure to macrophages.
Roger PM; Bermudez LE
Clin Immunol; 2001 Jun; 99(3):378-86. PubMed ID: 11358435
[TBL] [Abstract][Full Text] [Related]
17. The purinergic P2X7 receptor is not required for control of pulmonary Mycobacterium tuberculosis infection.
Myers AJ; Eilertson B; Fulton SA; Flynn JL; Canaday DH
Infect Immun; 2005 May; 73(5):3192-5. PubMed ID: 15845532
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of membrane TNF mediated host resistance is dependent on mycobacterial virulence.
Dambuza I; Allie N; Fick L; Johnston N; Fremond C; Mitchell J; Quesniaux VF; Ryffel B; Jacobs M
Tuberculosis (Edinb); 2008 May; 88(3):221-34. PubMed ID: 17950671
[TBL] [Abstract][Full Text] [Related]
19. The systemic and pulmonary LPS binding protein response to intratracheal lipopolysaccharide.
Gamble L; Bagby GJ; Quinton LJ; Happel KI; Mizgerd JP; Zhang P; Nelson S
Shock; 2009 Feb; 31(2):212-7. PubMed ID: 18520704
[TBL] [Abstract][Full Text] [Related]
20. Receptor for advanced glycation end products is protective during murine tuberculosis.
van Zoelen MA; Wieland CW; van der Windt GJ; Florquin S; Nawroth PP; Bierhaus A; van der Poll T
Mol Immunol; 2012 Oct; 52(3-4):183-9. PubMed ID: 22698798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
